Nyrada is leaps and bounds in treating brain injury and cardiovascular disease
Treat the cause - not the symptoms. It’s an old phrase but Australian drug developer Nyrada (ASX: NYR)
News
crisis
News
5GN’s one-stop, ultraspeed digital solution for critical infrastructure
Now more than ever society relies on ultra fast, reliable and secure digital experiences. 5G Networks (ASX: 5GN)
News
Novonix (ASX: NVX) powering the renewable futures needs
Last Wednesday at our weekly ‘Meet The CEOs’ briefing we were joined by Dr Chris Burns from Novonix
News
Economic uncertainty is a favourable market condition for Credit Intelligence
Credit Intelligence (CI1) is an ASX-listed fintech company experiencing tailwinds amidst the economic uncertainty of COVID-19 and a
News
Rhinomed’s step ladder in competitive US pharmacy sector
Rhinomed (ASX: RNO) radically improves the way people breathe, sleep, maintain their health and take medication. The company
News
The ASX Options Trading Game has launched
The new round of the ASX Options Trading Game is now open so make sure to create an
News
Manuka Resources IPO for gold and silver prospects
Manuka Resources, the nation's newest gold and silver producer, has launched its IPO. The company is looking to
News
Spirit Telecom grows 146% during COVID
Despite the tumultuous market and economic recession, ASX-listed Spirit Telecom (ASX: ST1) grew 146% in the four months
News
Neuroscientific Biopharmaceuticals positioned for Alzheimer’s breakthrough
Conditions like dementia and Alzheimer's disease have the most likelihood of a medical breakthrough in the next 10
News
Is the rally just a dead cat bounce? No one can know for sure – but that’s not necessarily a bad thing
The market's recent gains have come largely from retail investors entering the market but not everyone is convinced